Skip to main content
Log in

Effect of budesonide on hospitalization rates among children with acute asthma attending paediatric emergency department: a systematic review and meta-analysis

  • Meta-analysis
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Introduction

The efficacy of inhaled budesonide for managing moderate-to-severe acute exacerbations in children is not clear. Therefore, this study aimed to evaluate hospital admission rates, need for use of systemic corticosteroids, length of hospital stay and adverse events when inhaled budesonide is added to standard pediatric emergency department management of moderate-to-severe acute exacerbations of asthma.

Methods

A systematic search was conducted in PubMed, Scopus, CENTRAL (Cochrane Central Register of Controlled Trials) and Google scholar databases. Randomized controlled trials that evaluated the effect of nebulized budesonide in moderate-to-severe acute exacerbations of asthma in pediatric patients were included for this meta-analysis. Statistical analysis was done using STATA version 13.0.

Results

A total of 16 RCTs were included. Children receiving nebulized budesonide had 43% lower risk of being hospitalized (RR 0.57; 95% CI, 0.39; 0.85) and 66% lower risk of requiring systemic corticosteroids (RR 0.34; 95 % CI, 0.21; 0.55) compared with those receiving placebo. There were no differences in the length of hospital stay (Hedges’s g standardized mean difference − 1.53; 95% CI, − 3.64; 0.58) and risk of adverse events (RR 0.87, 95% CI; 0.65; 1.17) between the two groups. There was no evidence of publication bias for any of the outcomes considered.

Conclusion

The findings of this meta-analysis support the use of inhaled budesonide in reducing risk of hospitalization and the need for systemic corticosteroids among children with acute moderate-to-severe asthma exacerbation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med. 2006;355:2226–35.

    Article  CAS  Google Scholar 

  2. Subbarao P, Mandhane PJ, Sears MR. Asthma: epidemiology, etiology and risk factors. CMAJ. 2009;181:E181–90.

    Article  Google Scholar 

  3. NAE Asthma, PP. Third expert panel on the diagnosis and management of expert panel report 3: guidelines for the diagnosis and management of asthma. US: National Heart, Lung and Blood Institute; 2007.

    Google Scholar 

  4. Alangari AA. Corticosteroids in the treatment of acute asthma. Ann Thorac Med. 2014;9:187–92.

    Article  CAS  Google Scholar 

  5. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev. 2000;(2):CD002178. 

  6. Pedersen S, Steffensen G, Ekman I, Tönnesson M, Borgå O. Pharmacokinetics of budesonide in children with asthma. Eur J Clin Pharmacol. 1987;31:579–82.

    Article  CAS  Google Scholar 

  7. Papadopoulos NG, Arakawa H, Carlsen K-H, Custovic A, Gern J, Lemanske R, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67:976–97.

    Article  CAS  Google Scholar 

  8. Kearns N, Maijers I, Harper J, Beasley R, Weatherall M. Inhaled Corticosteroids in Acute Asthma: A Systemic Review and Meta-Analysis. J Allergy ClinImmunol Pract. 2019;8:605–17.

    Article  Google Scholar 

  9. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

    Article  Google Scholar 

  10. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. England: Wiley; 2008.

    Google Scholar 

  11. Alangari AA, Malhis N, Mubasher M, Al-Ghamedi N, Al-Tannir M, Riaz M, et al. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: a double-blind, randomized, controlled trial. Chest. 2014;145:772–8.

    Article  CAS  Google Scholar 

  12. Chen A, Zeng G, Chen R, Zhan J, Sun L, Huang S, et al. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology. 2013;18(Suppl 3):47–52.

    Article  Google Scholar 

  13. Chen A, Chen R, Zhan J, Huang S, Lin Y, Chen D, et al. The efficacy of nebulized budesonide in acute moderate to severe exacerbations of asthma in children. Zhonghua Jie He He Hu Xi Za Zhi. 2012;35:269–74.

    PubMed  Google Scholar 

  14. Razi CH, Akelma AZ, Harmanci K, Kocak M, Kuras CY. The Addition of inhaled budesonide to standard therapy shortens the length of stay in hospital for asthmatic preschool children: a randomized, double-blind. Placebo-Controlled Trial Int Arch Allergy Immunol. 2015;166:297–303.

    Article  CAS  Google Scholar 

  15. Razi CH, Cörüt N, Andıran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatr Pulmonol. 2017;52:720–8.

    Article  Google Scholar 

  16. Sekerel BE, Sackesen C, Tuncer A, Adalioglu G. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatr. 2005;94:1372–7.

    Article  Google Scholar 

  17. Singhi S, Banerjee S, Nanjundaswamy H. Inhaled budesonide in acute asthma. J Paediatr Child Health. 1999;35:483–7.

    Article  CAS  Google Scholar 

  18. Sung L, Osmond MH, Klassen TP. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad Emerg Med. 1998;5:209–13.

    Article  CAS  Google Scholar 

  19. Upham BD, Mollen CJ, Scarfone RJ, Seiden J, Chew A, Zorc JJ. Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. Acad Emerg Med. 2011;18:665–73.

    Article  Google Scholar 

  20. Milani GKM, RosárioFilho NA, Riedi CA, Figueiredo BC. Nebulized budesonide to treat acute asthma in children. J Pediatr (Rio J). 2004;80:106–12.

    Article  Google Scholar 

  21. Nuhoglu Y, Atas E, Nuhoglu C, Iscan M, Ozcay S. Acute effect of nebulized budesonide in asthmatic children. J Investig Allergol ClinImmunol. 2005;15:197–200.

    CAS  Google Scholar 

  22. Van Bever HP, Schuddinck L, Wojciechowski M, Stevens WJ. Aerosolized budesonide in asthmatic infants: a double blind study. Pediatr Pulmonol. 1990;9:177–80.

    Article  Google Scholar 

  23. de Blic J, Delacourt C, Le Bourgeois M, Mahut B, Ostinelli J, Caswell C, et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol. 1996;98:14–20.

    Article  Google Scholar 

  24. Pedersen S, Hansen OR. Budesonide treatment of moderate and severe asthma in children: a dose-response study. J Allergy Clin Immunol. 1995;95:29–33.

    Article  CAS  Google Scholar 

  25. Tsai YG, Lee MY, Yang KD, Chu DM, Yuh YS, Hung CH. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J Pediatr. 2001;139:433–7.

    Article  CAS  Google Scholar 

  26. Akhtaruzzaman M, Ahmed SU, Hoque MA, Choudhury AM, Hossain MA, Islam MN, et al. Effects of nebulized budesonide as an adjunct to standard treatment of asthma exacerbations: a randomized, double-blind, placebo-controlled trial. Mymensingh Med J. 2014;23:418–25.

    CAS  PubMed  Google Scholar 

  27. Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel). 2010;3:514–40.

    Article  CAS  Google Scholar 

  28. Edmonds ML, Milan SJ, Camargo CA, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev. 2012;12:CD02308.

    Google Scholar 

  29. Castro-Rodriguez JA, Pincheira MA, Escobar-Serna DP, Sossa-Briceño MP, Rodriguez-Martinez CE. Adding nebulized corticosteroids to systemic corticosteroids for acute asthma in children: a systematic review with meta-analysis. Pediatr Pulmonol. 2020;55:2508–17.

    Article  Google Scholar 

Download references

Funding

No funding was received.

Author information

Authors and Affiliations

Authors

Contributions

CL designed the project; CL and ZL were involved in data collection and data analysis; CL prepared the manuscript; ZL edited the manuscript; all authors read and approved the final manuscript.

Corresponding author

Correspondence to Zhang Liu.

Ethics declarations

Ethical approval

Not required for a systematic review.

Conflict of interest

There is no benefit has been received or will be received from any party related directly or indirectly to the subject of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (docx 344 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, CY., Liu, Z. Effect of budesonide on hospitalization rates among children with acute asthma attending paediatric emergency department: a systematic review and meta-analysis. World J Pediatr 17, 152–163 (2021). https://doi.org/10.1007/s12519-020-00403-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-020-00403-y

Keywords

Navigation